Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
CC transcript
Director departure
ELITE PHARMACEUTICALS INC (ELTP) Create: Alert

All | News | Filings
Date FiledTypeDescription
08/14/2023 8-K Quarterly results
Docs: "]"
07/17/2023 8-K Changes in Registrant's Certifying Accountant, Financial Statements and Exhibits  Interactive Data
06/29/2023 8-K Quarterly results
Docs: "Elite Pharmaceuticals, Inc. Reports Financial Results for the Fiscal Year Ended March 31, 2023 and Provides Conference Call Information Conference Call Scheduled for Friday, June 30 at 11:30 AM EDT"
05/03/2023 8-K Quarterly results
04/20/2023 8-K Quarterly results
02/28/2023 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
02/14/2023 8-K Quarterly results
Docs: "Elite Pharmaceuticals, Inc. Reports Financial Results for the Third Quarter of Fiscal Year 2023 ended December 31, 2022 and Provides Conference Call Information Conference Call Scheduled for Wednesday, February 15 at 11:30 AM EST"
12/22/2022 8-K Regulation FD Disclosure, Financial Statements and Exhibits  Interactive Data
Docs: "Dianne Will, Investor Relations"
11/28/2022 8-K Quarterly results
11/15/2022 8-K Quarterly results
11/10/2022 8-K Quarterly results
11/02/2022 8-K Quarterly results
09/07/2022 8-K Entry into a Material Definitive Agreement, Departure of Directors or Certain Officers; Election of Directors; Appointment of...
Docs: "EMPLOYMENT AGREEMENT"
08/26/2022 8-K Termination of a Material Definitive Agreement, Financial Statements and Exhibits  Interactive Data
08/15/2022 8-K Quarterly results
06/29/2022 8-K Quarterly results
06/29/2022 8-K Quarterly results
05/11/2022 8-K Quarterly results
04/18/2022 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
04/04/2022 8-K Regulation FD Disclosure, Financial Statements and Exhibits  Interactive Data
Docs: "For Elite Pharmaceuticals, Inc. Dianne Will, Investor Relations, 518-398-6222"
02/14/2022 8-K Quarterly results
Docs: "Elite Pharmaceuticals, Inc. Reports Financial Results for the Third Quarter of Fiscal Year Ended December 31, 2021 and Provides Conference Call Information Conference Call Scheduled for Tuesday, February 15 at 11:30 AM EST"
12/09/2021 8-K Quarterly results
12/02/2021 8-K Quarterly results
12/02/2021 8-K Quarterly results
08/16/2021 8-K Quarterly results
Docs: "Elite Pharmaceuticals, Inc. Reports Financial Results for the First Quarter of Fiscal Year 2022 Ended June 30, 2021 and Provides Conference Call Information Conference Call Scheduled for Tuesday, August 17 at 11:30 AM EDT"
06/14/2021 8-K Quarterly results
05/05/2021 8-K Quarterly results
04/29/2021 8-K Quarterly results
04/12/2021 8-K Quarterly results
02/16/2021 8-K Quarterly results
11/16/2020 8-K Quarterly results
Docs: "Elite Pharmaceuticals, Inc. Reports Financial Results For The Second Quarter of Fiscal Year 2021 Ended September 30, 2020 and Provides Conference Call Information Conference Call Scheduled for Tuesday, November 17 at 11:30 AM EST"
08/27/2020 8-K Quarterly results
08/17/2020 8-K Quarterly results
07/09/2020 8-K Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Financial Statements and Exhibits
Docs: "Purchase Agreement, by and between the Company and Lincoln Park Capital Fund, LLC",
"Registration Rights Agreement, by and between the Company and Lincoln Park Capital Fund, LLC"
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy